Clinical Trials Directory

Trials / Unknown

UnknownNCT02303639

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias. A Prospective, Randomized Multicentre Study.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Central Finland Hospital District · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study evaluates whether catheter based radiofrequency ablation is superior to optimized antiarrhythmic medical therapy in preventing ventricular tachyarrhythmia relapses in patients with ischemic heart disease and implantable cardioverter defibrillator.

Detailed description

The study is designed to evaluate whether catheter based radiofrequency ablation is superior to optimized antiarrhythmic medical therapy in preventing ventricular tachyarrhythmia relapses among patients with prior myocardial infarction and implantable cardioverter defibrillator (ICD). The patients have not been using using chronic antiarrhythmic medication. Primary end point is number of ICD therapies (defibrillations, cardioversions and antitachycardia pacing) and otherwise documented sustained ventricular tachycardia (duration more than 30 s or hemodynamically unstable ) or ventricular fibrillation episodes during 12 months follow-up period. Secondary end points include mortality, hospitalization for cardiac reason, health economics, quality of life and several ICD and arrhythmia related issues. Total length of the follow-up is at least two years.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency catheter ablationCatheter ablation with an open-irrigated tip ablation catheter and 3D electroanatomical mapping
DRUGAntiarrhythmic drug therapyAmiodarone (or sotalol) for prevention of VT/VF relapses

Timeline

Start date
2015-04-01
Primary completion
2017-06-01
Completion
2018-06-01
First posted
2014-12-01
Last updated
2016-09-01

Locations

2 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT02303639. Inclusion in this directory is not an endorsement.